| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| REIMB | REIMB_KELA(317)_ICD10(L20) | Topical pimecrolimus and tacrolimus, Atopic dermatitis | 1719 | |
| REIMB | REIMB_KELA(317)_ICD10(L200) | Topical pimecrolimus and tacrolimus, Besnier's prurigo | 931 | |
| REIMB | REIMB_KELA(134)_ICD10(L400) | General erythroderma, Psoriasis vulgaris | 194 | |
| REIMB | REIMB_KELA(134)_ICD10(L26) | General erythroderma, Exfoliative dermatitis | 91 | |
| REIMB | REIMB_KELA(134)_ICD9(NA) | General erythroderma, Name not found | 68 | |
| REIMB | REIMB_KELA(395)_ICD10(L20) | Dupilumab, Atopic dermatitis | 53 | |
| REIMB | REIMB_KELA(134)_ICD10(L20) | General erythroderma, Atopic dermatitis | 47 | |
| REIMB | REIMB_KELA(395)_ICD10(L200) | Dupilumab, Besnier's prurigo | 41 | |
| REIMB | REIMB_KELA(134)_ICD8(NA) | General erythroderma, Name not found | 23 | |
| REIMB | REIMB_KELA(395)_ICD10(J45) | Dupilumab, Asthma | 20 | |
| REIMB | REIMB_KELA(134)_ICD10(L200) | General erythroderma, Besnier's prurigo | 14 | |
| REIMB | REIMB_KELA(134)_ICD9(6961A) | General erythroderma, Psoriasis and similar disorders, Other psoriasis | 14 | |
| REIMB | REIMB_KELA(317)_ICD10(L209) | Topical pimecrolimus and tacrolimus, Atopic dermatitis, unspecified | 13 | |
| REIMB | REIMB_KELA(134)_ICD10(NA) | General erythroderma, Name not found | 9 | |
| REIMB | REIMB_KELA(395)_ICD10(J451) | Dupilumab, Nonallergic asthma | 6 | |
| REIMB | REIMB_KELA(134)_ICD10(L53) | General erythroderma, Other erythematous conditions | 5 | |
| REIMB | REIMB_KELA(395)_ICD10(J450) | Dupilumab, Predominantly allergic asthma | 5 |